CN100411648C - Medicine for treating atrophic arthritis - Google Patents

Medicine for treating atrophic arthritis Download PDF

Info

Publication number
CN100411648C
CN100411648C CNB2005100450485A CN200510045048A CN100411648C CN 100411648 C CN100411648 C CN 100411648C CN B2005100450485 A CNB2005100450485 A CN B2005100450485A CN 200510045048 A CN200510045048 A CN 200510045048A CN 100411648 C CN100411648 C CN 100411648C
Authority
CN
China
Prior art keywords
radix
grams
medicine
rheumatoid arthritis
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2005100450485A
Other languages
Chinese (zh)
Other versions
CN1785276A (en
Inventor
王显柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2005100450485A priority Critical patent/CN100411648C/en
Publication of CN1785276A publication Critical patent/CN1785276A/en
Application granted granted Critical
Publication of CN100411648C publication Critical patent/CN100411648C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a medicine for treating rheumatoid arthritis, which is prepared from the following Chinese medicines by a certain weight compounding ratio: bungarus minimus, ledebouriella root, dahurian angelica, prepared nux vomica, notoginseng, eucommia bark, radix dipsaci from Sichuan of China, pubescent angelica root, Chinese taxillus twig, earthworm, centipede, leech, angelica, cyathula root, licorice, ephedra and radix aconiti lateralis preparata. The present invention has the advantages of convenient oral administration, no toxic or side effect, no recurrence after healing and accurate curative effect. When the medicine of the present invention is used for treating rheumatoid arthritis, the effective rate is 100%, and the cure rate is 90%.

Description

The medicine of treatment rheumatoid arthritis
Technical field
The invention belongs to the ultrafine Chinese herb technical field, specifically a kind of medicine for the treatment of rheumatoid arthritis.
Background technology
Rheumatoid arthritis is by human righteousness's deficiency or Liver and kidney two void, muscles and bones is lost in moistening foster, be subjected to wind, cold, wet or exopathogen intrusion meridians, cause the meridians obturation, the retardance joint, with the passing of time qi stagnation hemagglutination causes extremities joint distortion, enlargement, joint joint stuffiness, numb pain, amyotrophy forms the maimed person.All adopt Western medicine to add hormone therapy for this type of sick doctor trained in Western medicine and relieve the pain, side effect is very big, and its rate that heals is extremely low, and can only take stopgap measures and to effect a permanent cure, and easily formation is residual in human body, influences the healthy of people and can cause other diseases, and the cost height causes very big economically burden to the people.What have utilizes treatment by Chinese herbs, then exists dialectical inaccurately, and it is not smart to fill a prescription, the shortcoming of DeGrain.
Purpose of the present invention just is to provide a kind of ultrafine Chinese herb preparation for the treatment of rheumatoid arthritis.But the Liver and kidney giving young employees remedial-courses in general knowledge and vocational skills, promoting the flow of QI in the collateral by warming the meridian, expelling wind and removing dampness, cold expelling relieves the pain, and fundamentally sets about reaching the purpose of treatment rheumatoid arthritis.Medicine of the present invention is formulated by pure Chinese medicine.Take the back determined curative effect, took effect in 5 to 10 days, human body is had no side effect, the lighter can cure a course of treatment, and heavy person can cure 2 to 3 courses of treatment, cures the back and is difficult for recurrence.
Summary of the invention
Solution of the present invention is based on the pathogeny and the treatment by Chinese herbs principle of rheumatoid arthritis, with reference to modern pharmacological research, select invigorating the liver and kidney, expelling wind and cold, promoting the flow of QI in the collateral by warming the meridian for use, the medicine that relieves the pain is formed, but the liver and the kidney tonifying, expelling wind and removing dampness, promoting the flow of QI in the collateral by warming the meridian, cold expelling relieve the pain, reach the purpose of treatment rheumatoid arthritis.
The present invention is made by following prescription and components in portion by weight:
Agkistrodon 4-6, Radix Saposhnikoviae 30-100, Radix Angelicae Dahuricae 30-100, Semen Strychni (processed) 50-100, Radix Notoginseng 10-50, Cortex Eucommiae 20-60, Radix Dipsaci 20-60, Radix Angelicae Pubescentis 10-50, Herba Taxilli 15-50, Pheretima 10-30, Scolopendra 7-20, Hirudo 10-20, Radix Angelicae Sinensis 10-50, Radix Cyathulae 10-30, Radix Glycyrrhizae 6-20, Herba Ephedrae 10-30, Radix Aconiti Lateralis Preparata 10-50.
Use the above-mentioned prescription of the present invention, treatment rheumatoid arthritis effect is obvious, has no side effect, and more the back is difficult for recurrence, effective percentage 100%, cure rate 90%.
Drug action mechanism of the present invention is as follows:
Agkistrodon: sweet in the mouth, salty, slightly warm in nature, poisonous, go into Liver Channel, have the merit of dispelling wind and removing obstruction in the collateral.(the same, as to see 363 pages)
Radix Saposhnikoviae: acrid in the mouth, sweet, slightly warm in nature, go into spleen, liver, urinary bladder channel, have the merit (the same, as to see 70 pages) that inducing diaphoresis to dispel wind, damp eliminating relieve the pain
The Radix Angelicae Dahuricae: acrid in the mouth, warm in nature, go into lung, taste warp, having dispels the wind relieves the pain, the merit of detumescence and apocenosis.(the same, as to see 380 pages)
Radix Dipsaci: bitter in the mouth, little suffering, warm in nature, go into liver, kidney channel, have the merit of invigorating the liver and kidney, bone and muscle strengthening.(the same, as to see 621 pages)
The Cortex Eucommiae: sweet in the mouth, little suffering, warm in nature, go into liver, kidney channel, have the merit of invigorating the liver and kidney, bone and muscle strengthening.(the same, as to see 620 pages)
Radix Notoginseng: mildly bitter flavor, warm in nature, go into liver, stomach warp, have hemostasis by removing blood stasis, the merit that relieves the pain of detumescence.(the same, as to see 527 pages)
Herba Taxilli: liver, kidney channel are equalled, gone into to sweet in the mouth, little hardship, property, has the merit of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling.(the same, as to see 613 pages)
Radix Angelicae Pubescentis: acrid in the mouth, hardship, warm in nature, go into kidney, urinary bladder channel, have the merit that wind-damp dispelling relieves the pain.(the same, as to see 354 pages)
Pheretima
Scolopendra: acrid in the mouth, warm in nature, go into Liver Channel, have suppressing liver-wind to relieve spasm, the merit of dispersing pathogen accumulation.(the same, as to see 383 pages)
Hirudo: salty in the mouth, hardship, property be flat, poisonous, go into Liver Channel, has the merit of removing blood stasis.(the same, as to see 561 pages)
Herba Ephedrae: lung meridian, urinary bladder channel are put down, gone into to acrid in the mouth, little hardship, property, has the merit of the cold expelling of delivering, inducing diuresis to remove edema.(the same, as to see 65 pages)
Radix Aconiti Lateralis Preparata: acrid in the mouth, hot in nature, poisonous, go into the heart, kidney, spleen channel, have the merit of warming the kidney to invigorate YANG, cold relieving pain relieving.(the same, as to see 234 pages)
Radix Cyathulae: liver, kidney channel are equalled, gone into to bitter in the mouth, acid, property, has the merit in blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, sharp joint.(the same, as to see 551 pages)
Radix Angelicae Sinensis: sweet in the mouth, suffering, hardship, warm in nature, go into liver, spleen, heart channel, have the merit of tonifying blood and regulating menstruation, promoting blood circulation to relieve pain.(the same, as to see 611 pages)
Semen Strychni (processed): bitter in the mouth, cold in nature, the merit that have the meridian dredging, relieves the pain.(see Chinese medicine, the Jiangsu People's Press sees 239 pages, the 2nd printing February in 1973)
Chinese medicine is thought the pathogeny of rheumatoid arthritis, be by human righteousness's deficiency or Liver and kidney two void, insufficiency of vital energy and blood, cause wind, cold, wet or exopathogen intrusion in an opponent's defence, flee meridians, the meridians of being detained, the retardance joint, with the passing of time qi stagnation hemagglutination causes extremities joint distortion, enlargement, joint joint stuffiness, numb pain, amyotrophy to form the maimed person., among the present invention based on the Cortex Eucommiae, Radix Dipsaci, Semen Strychni (processed), invigorating the liver and kidney, bone and muscle strengthening, relieve the pain.Radix Angelicae Sinensis, Radix Notoginseng, Stigma Croci, Hirudo, Scolopendra, Radix Cyathulae, blood circulation promoting and blood stasis dispelling, expel wind to dredge collateral are auxilliary.Assistant with Radix Angelicae Pubescentis, Radix Saposhnikoviae, the Radix Angelicae Dahuricae, Herba Taxilli, Pheretima, Herba Ephedrae, Radix Aconiti Lateralis Preparata expelling wind and removing dampness, deliver cold expelling.The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.All medicines are synthetic, have the liver and the kidney tonifying, promoting blood circulation to remove blood stasis, expelling wind and removing dampness, deliver the merit of cold expelling, promoting the flow of QI in the collateral by warming the meridian, reach the purpose of treatment rheumatoid arthritis.
Specific embodiments
The invention will be further described below in conjunction with embodiment:
Embodiment: 4 of Agkistrodons, Semen Strychni (processed) 80 grams, Radix Saposhnikoviae 50 grams, the Radix Angelicae Dahuricae 50 grams, Radix Notoginseng 10 grams, the Cortex Eucommiae 30 grams, Radix Dipsaci 30 grams, Radix Angelicae Pubescentis 20 grams, Radix Glycyrrhizae 10 grams, Herba Taxilli 30 grams, Radix Angelicae Sinensis 20 grams, Radix Cyathulae 20 grams, Pheretima 20 grams, 10 of Scolopendras, Hirudo 20 grams, Herba Ephedrae 20 grams, Radix Aconiti Lateralis Preparata 20 grams.To add medicine to and make micropowder (300 order) altogether, mix homogeneously is obeyed 2 grams at every turn and is got final product, day clothes 2 times, one after each meal.
For showing the curative effect of medicine of the present invention, the 800 routine patients that treat are divided into matched group and experimental group, upright shelves stay to look into is added up contrast.Matched group medication conventional therapy, experimental group Drug therapy of the present invention all is effectively with the sx, and transference cure is recovery from illness, and statistical result is as follows.
Table 1: contrast curative effect situation
Table 2: experimental group curative effect situation
Figure C20051004504800072

Claims (2)

1. medicine for the treatment of rheumatoid arthritis, it is characterized in that: it is by the medicine that following raw material is formed and weight proportion is made, Agkistrodon 4-6, Radix Saposhnikoviae 30-100, Radix Angelicae Dahuricae 30-100, Semen Strychni (processed) 50-100, Radix Notoginseng 10-50, Cortex Eucommiae 20-60, Radix Dipsaci 20-60, Radix Angelicae Pubescentis 10-50, Herba Taxilli 15-50, Pheretima 10-30, Scolopendra 7-20, Hirudo 10-20, Herba Ephedrae 10-30, Radix Aconiti Lateralis Preparata 10-50, Radix Cyathulae 10-30, Radix Glycyrrhizae 6-20, Radix Angelicae Sinensis 10-50.
2. medicine for the treatment of rheumatoid arthritis, it is characterized in that: it is by the medicine that following raw material is formed and weight proportion is made, and 4 of Agkistrodons, Semen Strychni (processed) 80 grams, Radix Saposhnikoviae 50 grams, the Radix Angelicae Dahuricae 50 grams, Radix Notoginseng 10 grams, the Cortex Eucommiae 30 grams, Radix Dipsaci 30 grams, Radix Angelicae Pubescentis 20 grams, Herba Taxilli 30 grams, Pheretima 20 grams, 10 of Scolopendras, Hirudo 20 grams, Herba Ephedrae 20 grams, Radix Aconiti Lateralis Preparata 20 grams, Radix Cyathulae 20 grams, Radix Glycyrrhizae 10 restrain, Radix Angelicae Sinensis 20 grams.
CNB2005100450485A 2005-11-08 2005-11-08 Medicine for treating atrophic arthritis Expired - Fee Related CN100411648C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100450485A CN100411648C (en) 2005-11-08 2005-11-08 Medicine for treating atrophic arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100450485A CN100411648C (en) 2005-11-08 2005-11-08 Medicine for treating atrophic arthritis

Publications (2)

Publication Number Publication Date
CN1785276A CN1785276A (en) 2006-06-14
CN100411648C true CN100411648C (en) 2008-08-20

Family

ID=36782945

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100450485A Expired - Fee Related CN100411648C (en) 2005-11-08 2005-11-08 Medicine for treating atrophic arthritis

Country Status (1)

Country Link
CN (1) CN100411648C (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101129630B (en) * 2007-09-07 2010-05-19 李金伟 Medicament for treating rheumatism, arthritis pauperum
CN103202994B (en) * 2013-04-15 2017-06-16 文水生 A kind of charcoal fire medication technology for treating treating rheumatic ostealgia
CN104623607B (en) * 2015-02-05 2018-04-06 张德东 A kind of Chinese medicine composition for treating rheumatic and rheumatoid diseases
CN106421228A (en) * 2016-11-10 2017-02-22 时金臣 Traditional Chinese medicine composition for treating rheumatic and rheumatoid and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1164406A (en) * 1996-05-08 1997-11-12 龙兰桂 Drug for curing rheumatoid disease and its preparing method
CN1184655A (en) * 1996-12-13 1998-06-17 李风学 Drug for treating rheumatoid disease
CN1686499A (en) * 2005-03-21 2005-10-26 朱春营 Articular pain relieving pill

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1164406A (en) * 1996-05-08 1997-11-12 龙兰桂 Drug for curing rheumatoid disease and its preparing method
CN1184655A (en) * 1996-12-13 1998-06-17 李风学 Drug for treating rheumatoid disease
CN1686499A (en) * 2005-03-21 2005-10-26 朱春营 Articular pain relieving pill

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
中医药治疗类风湿性关节炎并贫血. 李华,刘健.《中国临床保健杂志》,第8卷第2期. 2005
中医药治疗类风湿性关节炎并贫血. 李华,刘健.《中国临床保健杂志》,第8卷第2期. 2005 *
中药外敷治疗关节炎. 张洪军.《健康报》. 2002
中药外敷治疗关节炎. 张洪军.《健康报》. 2002 *

Also Published As

Publication number Publication date
CN1785276A (en) 2006-06-14

Similar Documents

Publication Publication Date Title
CN100548350C (en) A kind of Chinese medicine for the treatment of thromboangiitis obliterans
CN102114228B (en) Traditional Chinese medicine preparation for externally treating cold-dampness arthralgia syndrome
CN100488549C (en) Externally applied medicament for treating rheumatism
CN101721664A (en) Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN100411648C (en) Medicine for treating atrophic arthritis
CN102475868A (en) Anti-rheumatism medicinal liquor
CN104667035A (en) Medicament for treating gout
CN101417003A (en) Traditional Chinese medicine composition for treating vertebras disease
CN1686409A (en) Bone impediment dispersion sticking plaster
CN101015641A (en) Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder
CN101129630B (en) Medicament for treating rheumatism, arthritis pauperum
CN103550446B (en) Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition
CN106362066A (en) Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof
CN100411645C (en) Hyperosteogeny treating medicine
CN105233001A (en) Traditional Chinese medicine for treating male sexual dysfunction and infertility and preparation method of traditional Chinese medicine
CN104758527A (en) Traditional Chinese medicine composition for treating pain in waists and legs
CN104383175A (en) Medicine for treating chronic osteomyelitis and preparation method of medicine
CN103191247A (en) Traditional Chinese medicine bag for stone needle ironing moxibustion
CN105194411A (en) Formula of traditional Chinese medicine for treating scapulobumeral periarthritis
CN106074992A (en) A kind of medical herbs for oral administration treating chest traumatic injury wound and using method thereof
CN106110217A (en) A kind of medicated wine for treating cervical spondylosis
CN1698801A (en) Capsule for treating hemiplegia and rheumatism
CN1087615C (en) Shenkangsan-medicine for treating nephrosis
CN105194038A (en) Medicine composition for preventing and treating Zimen traumatic injury and rheumatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee